7TZO image
Deposition Date 2022-02-16
Release Date 2023-01-11
Last Version Date 2024-06-12
Entry Detail
PDB ID:
7TZO
Title:
The apo structure of human mTORC2 complex
Biological Source:
Source Organism:
Homo sapiens (Taxon ID: 9606)
Host Organism:
Method Details:
Experimental Method:
Resolution:
3.28 Å
Aggregation State:
3D ARRAY
Reconstruction Method:
SINGLE PARTICLE
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:Serine/threonine-protein kinase mTOR
Gene (Uniprot):MTOR
Chain IDs:A, B
Chain Length:2674
Number of Molecules:2
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Molecule:Target of rapamycin complex subunit LST8
Gene (Uniprot):MLST8
Chain IDs:C, D
Chain Length:347
Number of Molecules:2
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Molecule:Rapamycin-insensitive companion of mTOR
Gene (Uniprot):RICTOR
Chain IDs:E, F
Chain Length:1720
Number of Molecules:2
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Molecule:Target of rapamycin complex 2 subunit MAPKAP1
Gene (Uniprot):MAPKAP1
Chain IDs:G, H
Chain Length:538
Number of Molecules:2
Biological Source:Homo sapiens
Ligand Molecules
Primary Citation
Interactions between mTORC2 core subunits Rictor and mSin1 dictate selective and context-dependent phosphorylation of substrate kinases SGK1 and Akt.
J.Biol.Chem. 298 102288 102288 (2022)
PMID: 35926713 DOI: 10.1016/j.jbc.2022.102288

Abstact

Mechanistic target of rapamycin complex 2 (mTORC2) is a multi-subunit kinase complex, central to multiple essential signaling pathways. Two core subunits, Rictor and mSin1, distinguish it from the related mTORC1 and support context-dependent phosphorylation of its substrates. mTORC2 structures have been determined previously; however, important questions remain, particularly regarding the structural determinants mediating substrate specificity and context-dependent activity. Here, we used cryo-EM to obtain high-resolution structures of the human mTORC2 apo-complex in the presence of substrates Akt and SGK1. Using functional assays, we then tested predictions suggested by substrate-induced structural changes in mTORC2. For the first time, we visualized in the apo-state the side chain interactions between Rictor and mTOR that sterically occlude recruitment of mTORC1 substrates and confer resistance to the mTORC1 inhibitor rapamycin. Also in the apo-state, we observed that mSin1 formed extensive contacts with Rictor via a pair of short α-helices nestled between two Rictor helical repeat clusters, as well as by an extended strand that makes multiple weak contacts with Rictor helical cluster 1. In co-complex structures, we found that SGK1, but not Akt, markedly altered the conformation of the mSin1 N-terminal extended strand, disrupting multiple weak interactions while inducing a large rotation of mSin1 residue Arg-83, which then interacts with a patch of negatively charged residues within Rictor. Finally, we demonstrate mutation of Arg-83 to Ala selectively disrupts mTORC2-dependent phosphorylation of SGK1, but not of Akt, supporting context-dependent substrate selection. These findings provide new structural and functional insights into mTORC2 specificity and context-dependent activity.

Legend

Protein

Chemical

Disease

Primary Citation of related structures